|
US4164559A
(en)
|
1977-09-21 |
1979-08-14 |
Cornell Research Foundation, Inc. |
Collagen drug delivery device
|
|
ES8401486A1
(es)
|
1981-11-10 |
1983-12-01 |
Wellcome Found |
Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
|
|
US4474752A
(en)
|
1983-05-16 |
1984-10-02 |
Merck & Co., Inc. |
Drug delivery system utilizing thermosetting gels
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
EP0410509A1
(en)
|
1989-07-25 |
1991-01-30 |
Duphar International Research B.V |
New substituted 1H-indazole-3-carboxamides
|
|
GB9414139D0
(en)
|
1994-07-13 |
1994-08-31 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6440102B1
(en)
|
1998-07-23 |
2002-08-27 |
Durect Corporation |
Fluid transfer and diagnostic system for treating the inner ear
|
|
DE19853299C2
(de)
|
1998-11-19 |
2003-04-03 |
Thomas Lenarz |
Katheter zur Applikation von Medikamenten in Flüssigkeitsräumen des menschlichen Innenohrs
|
|
US6120484A
(en)
|
1999-02-17 |
2000-09-19 |
Silverstein; Herbert |
Otological implant for delivery of medicament and method of using same
|
|
ES2258459T3
(es)
|
1999-05-21 |
2006-09-01 |
Bristol-Myers Squibb Company |
Pirrolotriazinas inhibidoras de quinasas.
|
|
PT1194425E
(pt)
|
1999-06-23 |
2005-10-31 |
Aventis Pharma Gmbh |
Benzimidazoles substituidos
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
TWI262914B
(en)
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
|
US6844367B1
(en)
|
1999-09-17 |
2005-01-18 |
Millennium Pharmaceuticals, Inc. |
Benzamides and related inhibitors of factor Xa
|
|
US6967023B1
(en)
|
2000-01-10 |
2005-11-22 |
Foamix, Ltd. |
Pharmaceutical and cosmetic carrier or composition for topical application
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
US6897231B2
(en)
|
2000-07-31 |
2005-05-24 |
Signal Pharmaceuticals, Inc. |
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
|
|
US20050009876A1
(en)
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
|
DK1318997T3
(da)
|
2000-09-15 |
2006-09-25 |
Vertex Pharma |
Pyrazolforbindelser der er nyttige som proteinkinase-inhibitorer
|
|
US7105532B2
(en)
|
2000-12-19 |
2006-09-12 |
Smithkline Beecham Corporation |
Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors
|
|
US20050192262A1
(en)
|
2001-03-13 |
2005-09-01 |
Tomas Hagstrom |
Treatment of tumours
|
|
DE60232669D1
(de)
|
2001-04-30 |
2009-07-30 |
Vertex Pharma |
Inhibitoren von gsk-3 und kristallstrukturen von gsk-3beta-protein und -proteinkomplexen
|
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
US7642278B2
(en)
|
2001-07-03 |
2010-01-05 |
Novartis Vaccines And Diagnostics, Inc. |
Indazole benzimidazole compounds
|
|
JP2004536113A
(ja)
|
2001-07-03 |
2004-12-02 |
カイロン コーポレイション |
チロシンキナーゼおよびセリン／スレオニンキナーゼのインヒビターとしてのインダゾールベンズイミダゾール化合物
|
|
WO2004043335A2
(en)
|
2001-09-13 |
2004-05-27 |
Genesoft, Inc. |
Methods of treating infection by drug resistant bacteria
|
|
US7101884B2
(en)
|
2001-09-14 |
2006-09-05 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US6648873B2
(en)
|
2001-09-21 |
2003-11-18 |
Durect Corp. |
Aural catheter system including anchor balloon and balloon inflation device
|
|
FR2831536A1
(fr)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
|
CN1589269A
(zh)
|
2001-10-26 |
2005-03-02 |
康涅狄格大学 |
杂1,2－二氢化茚:一类新型有效的大麻配体
|
|
US6897208B2
(en)
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
|
MXPA04003954A
(es)
|
2001-10-26 |
2004-11-29 |
Aventis Pharma Inc |
Bencimidazoles.
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
MXPA04008130A
(es)
|
2002-02-19 |
2004-11-26 |
Pharmacia Corp |
Derivados triciclicos de pirazol para el tratamiento de la inflamacion.
|
|
JP2005529850A
(ja)
|
2002-02-19 |
2005-10-06 |
ファルマシア・イタリア・エス・ピー・エー |
三環系ピラゾール誘導体、その製造方法および抗腫瘍剤としてのその使用
|
|
EP1506176B1
(en)
|
2002-05-17 |
2013-04-24 |
Pfizer Italia S.r.l. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
CN1656079A
(zh)
|
2002-05-31 |
2005-08-17 |
卫材株式会社 |
吡唑化合物和含有该化合物的药物组合物
|
|
AU2003240488A1
(en)
|
2002-06-04 |
2003-12-19 |
Neogenesis Pharmaceuticals, Inc. |
Pyrazolo` 1,5a! pyrimidine compounds as antiviral agents
|
|
US7449488B2
(en)
|
2002-06-04 |
2008-11-11 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
|
US20050282733A1
(en)
|
2002-06-27 |
2005-12-22 |
Prins Johannes B |
Differentiation modulating agents and uses therefor
|
|
GB0218625D0
(en)
|
2002-08-10 |
2002-09-18 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
FR2845382A1
(fr)
|
2002-10-02 |
2004-04-09 |
Sanofi Synthelabo |
Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
|
|
KR101312736B1
(ko)
|
2003-02-27 |
2013-09-27 |
팔라우 파르마 에스에이 |
피라졸로피리딘 유도체
|
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
|
DE60319158T2
(de)
|
2003-07-03 |
2009-02-05 |
Aventis Pharmaceuticals Inc. |
Pyrazoloisochinolinenderivaten als kinase inhibitoren
|
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
|
NZ544756A
(en)
|
2003-07-22 |
2009-09-25 |
Astex Therapeutics Ltd |
3,4-Disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
|
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
|
GT200400136A
(es)
|
2003-07-30 |
2005-05-02 |
|
Compuestos de indazol 3,5-disustituidos, composiciones farmaceuticas y metodos para intervenir en o inhibirlaproliferacion celular.
|
|
US20050090529A1
(en)
|
2003-07-31 |
2005-04-28 |
Pfizer Inc |
3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
|
WO2005014554A1
(en)
|
2003-08-08 |
2005-02-17 |
Astex Therapeutics Limited |
1h-indazole-3-carboxamide compounds as mapkap kinase modulators
|
|
US8969372B2
(en)
|
2003-11-14 |
2015-03-03 |
Aptose Boisciences Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
|
EP1532980A1
(en)
|
2003-11-24 |
2005-05-25 |
Novo Nordisk A/S |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
|
|
FR2864084B1
(fr)
|
2003-12-17 |
2006-02-10 |
Aventis Pharma Sa |
Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments
|
|
FR2867778B1
(fr)
|
2004-03-16 |
2006-06-09 |
Sanofi Synthelabo |
Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
|
|
CA2560741C
(en)
|
2004-03-25 |
2013-08-06 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
|
|
JP2007534692A
(ja)
|
2004-04-22 |
2007-11-29 |
メモリー・ファーマシューティカルズ・コーポレイション |
インドール、１ｈ−インダゾール、１，２−ベンズイソキサゾール、１，２−ベンゾイソチアゾール、ならびにその調製および使用
|
|
WO2005110410A2
(en)
|
2004-05-14 |
2005-11-24 |
Abbott Laboratories |
Kinase inhibitors as therapeutic agents
|
|
WO2006003440A1
(en)
|
2004-07-05 |
2006-01-12 |
Astex Therapeutics Limited |
3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors
|
|
BRPI0513899A
(pt)
|
2004-07-27 |
2008-05-20 |
Sgx Pharmaceuticals Inc |
moduladores de cinase heterocìclica de anel fundido
|
|
US7626021B2
(en)
|
2004-07-27 |
2009-12-01 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
TW200618800A
(en)
|
2004-08-03 |
2006-06-16 |
Uriach Y Compania S A J |
Heterocyclic compounds
|
|
WO2006024945A1
(en)
|
2004-09-03 |
2006-03-09 |
Pfizer Inc. |
Pharmaceutical compositions comprising a cdk inhibitor
|
|
US7652043B2
(en)
|
2004-09-29 |
2010-01-26 |
The Johns Hopkins University |
WNT pathway antagonists
|
|
WO2006054143A1
(en)
|
2004-11-17 |
2006-05-26 |
Pfizer Inc. |
Polymorphs of {5-[3-(4,6-difluoro-1h-benzoimidazol-2-yl)-1h-indazol-5-yl]-4-methyl-pyridin-3-ylmethyl}-ethyl-amine
|
|
US20060116519A1
(en)
|
2004-11-17 |
2006-06-01 |
Agouron Pharmaceuticals, Inc. |
Synthesis of 5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester
|
|
US20060127388A1
(en)
|
2004-12-10 |
2006-06-15 |
Wyeth |
Variants of glycogen synthase kinase 3 and uses thereof
|
|
US20060142247A1
(en)
|
2004-12-17 |
2006-06-29 |
Guy Georges |
Tricyclic heterocycles
|
|
EP2395000A1
(en)
*
|
2004-12-30 |
2011-12-14 |
Astex Therapeutics Limited |
Benzimidazole compounds that modulate the activity of CDK, GSK and aurora kinases
|
|
WO2008007113A2
(en)
|
2006-07-14 |
2008-01-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
EP1861161A4
(en)
|
2005-01-24 |
2012-05-16 |
Neurosystec Corp |
APPARATUS AND METHOD FOR DISPENSING THERAPEUTIC AND / OR OTHER AGENTS IN THE INTERNAL EAR AND OTHER FABRICS
|
|
WO2006130673A1
(en)
|
2005-05-31 |
2006-12-07 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
|
WO2007023111A2
(en)
|
2005-08-25 |
2007-03-01 |
F. Hoffmann-La Roche Ag |
P38 map kinase inhibitors and methods for using the same
|
|
US8106066B2
(en)
|
2005-09-23 |
2012-01-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
|
UY29825A1
(es)
|
2005-10-03 |
2007-05-31 |
Astrazeneca Ab |
Derivados sustituidos de 3h-imidazol-(4,5 b (beta))piridina-2-il benzoatos y benzamidas, composiciones farmacéuticas que los contienen y aplicaciones
|
|
AR057987A1
(es)
|
2005-11-24 |
2008-01-09 |
Astrazeneca Ab |
Compuestos agonistas de cb1 (receptor cannabinoide)
|
|
WO2007077435A1
(en)
|
2005-12-30 |
2007-07-12 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
GB0602178D0
(en)
|
2006-02-03 |
2006-03-15 |
Merck Sharp & Dohme |
Therapeutic treatment
|
|
CA2645892A1
(en)
|
2006-03-23 |
2007-09-27 |
F. Hoffmann-La Roche Ag |
Substituted indazole derivatives, their manufacture and use as pharmaceutical agents
|
|
CN101437519A
(zh)
|
2006-03-31 |
2009-05-20 |
艾博特公司 |
吲唑化合物
|
|
EP2044051B1
(en)
|
2006-06-22 |
2010-01-27 |
BIOVITRUM AB (publ) |
Pyridine and pyrazine derivatives as mnk kinase inhibitors
|
|
US7638518B2
(en)
|
2006-10-17 |
2009-12-29 |
Janssen Pharmaceutica |
Substituted pyrazole kinase inhibitors
|
|
WO2008061109A2
(en)
|
2006-11-15 |
2008-05-22 |
Forest Laboratories Holdings Limited |
Indazole derivatives useful as melanin concentrating receptor ligands
|
|
EP1932834B1
(en)
|
2006-12-11 |
2011-04-27 |
The Genetics Company, Inc. |
Aromatic 1,4-DI-Carboxylamides and their use
|
|
EP1932830A1
(en)
|
2006-12-11 |
2008-06-18 |
The Genetics Company, Inc. |
Sulfonamides and their use as a medicament
|
|
CL2007003609A1
(es)
|
2006-12-14 |
2008-07-25 |
Bayer Schering Pharma Ag |
Compuestos derivados de dihidropiridinas sustituidas; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; proceso para producir la composicion farmaceutica; y uso en el tratamiento de una enfermedad mejorada con la inhibicion
|
|
EP2078020A4
(en)
|
2007-04-10 |
2011-10-19 |
Sgx Pharmaceuticals Inc |
HETEROCYCLIC MODULATORS WITH FUSED CYCLES FOR KINASES
|
|
EP2148865B1
(en)
|
2007-04-30 |
2017-05-17 |
Genentech, Inc. |
Pyrazole inhibitors of wnt signaling
|
|
MX354256B
(es)
|
2007-05-10 |
2018-02-20 |
Avalon Pharmaceuticals |
Derivados de fluoreno, antraceno, xanteno, dibenzosuberona y acridina y usos de ellos.
|
|
US20080287452A1
(en)
|
2007-05-16 |
2008-11-20 |
Wyeth |
Heteroaryl/aryl pyrimidine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
|
|
WO2008147713A1
(en)
|
2007-05-24 |
2008-12-04 |
The Regents Of The University Of California |
Wnt signaling inhibitors, and methods for making and using them
|
|
TW200908968A
(en)
|
2007-05-29 |
2009-03-01 |
Sgx Pharmaceuticals Inc |
Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
|
|
WO2008150845A1
(en)
|
2007-05-31 |
2008-12-11 |
Vanderbilt University |
Screening for wnt pathway modulators and pyrvinium for the treatment of cance
|
|
SG182187A1
(en)
|
2007-06-08 |
2012-07-30 |
Abbott Gmbh & Co Kg |
5-heteroaryl substituted indazoles as kinase inhibitors
|
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
|
WO2008156757A1
(en)
|
2007-06-19 |
2008-12-24 |
Takeda Pharmaceutical Company Limited |
Indazole compounds for activating glucokinase
|
|
FR2917735B1
(fr)
|
2007-06-21 |
2009-09-04 |
Sanofi Aventis Sa |
Nouveaux indazoles substitutes, leur preparation et leur utilisation en therapeutique
|
|
WO2009011850A2
(en)
|
2007-07-16 |
2009-01-22 |
Abbott Laboratories |
Novel therapeutic compounds
|
|
JP2010535169A
(ja)
|
2007-08-02 |
2010-11-18 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
プロテインキナーゼ阻害薬と組み合わせられたモルホリニルアントラサイクリン誘導体
|
|
RU2350271C1
(ru)
|
2007-08-20 |
2009-03-27 |
Федеральное государственное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова Федерального агентства по высокотехнологичной медицинской помощи", ФГУ "РНЦ "ВТО" им. акад. Г.А. Илизарова Росмедтехнологий" |
Способ лечения ранних стадий остеоартроза тазобедренного сустава
|
|
EP2185556A1
(en)
|
2007-08-27 |
2010-05-19 |
Wyeth a Corporation of the State of Delaware |
Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
|
|
WO2009061345A2
(en)
|
2007-11-07 |
2009-05-14 |
Cornell Research Foundation, Inc. |
Targeting cdk4 and cdk6 in cancer therapy
|
|
PL2231662T3
(pl)
|
2007-12-19 |
2011-11-30 |
Genentech Inc |
8-anilinoimidazopirydyny oraz ich zastosowanie jako czynników przeciwnowotworowych i/lub przeciwzapalnych
|
|
AU2009260503B2
(en)
*
|
2008-05-27 |
2014-03-27 |
The Board Of Regents Of The University Of Texas System |
Wnt protein signalling inhibitors
|
|
KR101061599B1
(ko)
|
2008-12-05 |
2011-09-02 |
한국과학기술연구원 |
비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
CN101440092B
(zh)
|
2008-12-25 |
2010-11-17 |
浙江大学 |
2-吲唑-4-氮杂吲哚-5-氨基衍生物及制备和应用
|
|
EP2408744A1
(en)
|
2009-03-18 |
2012-01-25 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
|
|
WO2010111060A1
(en)
|
2009-03-23 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
P2x3, receptor antagonists for treatment of pain
|
|
CA2761896A1
(en)
|
2009-05-13 |
2010-11-18 |
The University Of North Carolina At Chapel Hill |
Cyclin dependent kinase inhibitors and methods of use
|
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
|
WO2011011722A1
(en)
|
2009-07-23 |
2011-01-27 |
Vanderbilt University |
Substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators
|
|
PL2464232T3
(pl)
|
2009-08-10 |
2016-04-29 |
Samumed Llc |
Indazolowe inhibitory szlaku sygnałowego Wnt i ich zastosowania terapeutyczne
|
|
JP2013501792A
(ja)
|
2009-08-10 |
2013-01-17 |
サミュメッド リミテッド ライアビリティ カンパニー |
Ｗｎｔ／ｂ−カテニンシグナル伝達経路阻害剤としてのインダゾールおよびその治療的使用
|
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
|
PT2516433E
(pt)
|
2009-12-21 |
2014-09-03 |
Array Biopharma Inc |
Compostos de n-(1h-indazol-4-il)imidazo[1,2- a]piridina-3 carboxamida substituída como inibidores de cfms
|
|
US8450340B2
(en)
|
2009-12-21 |
2013-05-28 |
Samumed, Llc |
1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
KR101792895B1
(ko)
|
2010-04-06 |
2017-11-02 |
피터 맥칼룸 캔서 인스티튜트 |
방사선 보호 화합물 및 방법
|
|
DE102010043379A1
(de)
|
2010-11-04 |
2012-05-10 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung
|
|
WO2012068589A2
(en)
|
2010-11-19 |
2012-05-24 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
DK2663561T3
(en)
|
2011-01-13 |
2016-06-06 |
Novartis Ag |
New heterocyclic derivatives and their use in treating neurological disorders
|
|
US8889684B2
(en)
|
2011-02-02 |
2014-11-18 |
Boehringer Ingelheim International Gmbh |
Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
|
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
US8569511B2
(en)
|
2011-04-01 |
2013-10-29 |
University Of Utah Research Foundation |
Substituted 3-(1H-benzo[d]imidazol-2-yl)-1H-indazole analogs as inhibitors of the PDK1 kinase
|
|
WO2013019901A2
(en)
|
2011-08-02 |
2013-02-07 |
Buck Institute For Research On Aging |
Tropinol esters and related compounds to promote normal processing of app
|
|
BR112014003296A2
(pt)
|
2011-08-12 |
2017-03-14 |
Hoffmann La Roche |
composto, composição farmacêutica, processo para a preparação de uma composição farmacêutica, método para o tratamento de uma doença ou distúrbio, conjunto para o tratamento de uma condição mediada pela quinase pim e utilização do composto
|
|
WO2013024011A1
(en)
|
2011-08-12 |
2013-02-21 |
F. Hoffmann-La Roche Ag |
Indazole compounds, compositions and methods of use
|
|
EP2763990B1
(en)
|
2011-09-01 |
2017-02-22 |
F. Hoffmann-La Roche AG |
Pyrrolopyrazine kinase inhibitors
|
|
EP3473099A1
(en)
|
2011-09-14 |
2019-04-24 |
Samumed, LLC |
Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
|
|
PL2810198T3
(pl)
|
2012-01-30 |
2024-01-22 |
Universiteit Gent |
Związki przeciwinwazyjne
|
|
WO2013142817A2
(en)
|
2012-03-23 |
2013-09-26 |
Dennis Brown |
Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
|
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
US9056874B2
(en)
|
2012-05-04 |
2015-06-16 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
CN107417707A
(zh)
|
2012-05-04 |
2017-12-01 |
萨穆梅德有限公司 |
1H‑吡唑并[3,4‑b]吡啶及其治疗应用
|
|
AU2013255894A1
(en)
|
2012-05-04 |
2014-11-13 |
Basf Se |
Substituted pyrazole-containing compounds and their use as pesticides
|
|
WO2014110086A2
(en)
|
2013-01-08 |
2014-07-17 |
Samumed, Llc |
3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof
|
|
US9346812B2
(en)
|
2013-01-16 |
2016-05-24 |
Signal Pharmaceuticals, Llc |
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
|
|
US9327886B2
(en)
|
2013-03-13 |
2016-05-03 |
Bayer Healthcare Llc |
Vial container with collar cap
|
|
DK3269716T3
(da)
|
2013-03-14 |
2020-10-19 |
Galapagos Nv |
Hidtil ukendte forbindelser og farmaceutiske sammensætninger deraf til behandling af inflammatoriske lidelser
|
|
FR3011239A1
(fr)
|
2013-10-01 |
2015-04-03 |
Univ Claude Bernard Lyon |
Nouveaux derives comprenant un groupe pyrazole et un groupe indole, utiles en tant qu'inhibiteurs de la kinase gsk3
|
|
EP3119393A4
(en)
|
2014-03-20 |
2018-02-28 |
Samumed, LLC |
5-substituted indazole-3-carboxamides and preparation and use thereof
|
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
US9538272B2
(en)
|
2014-09-08 |
2017-01-03 |
Apple Inc. |
Acoustic mesh and methods of use for electronic devices
|
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040188A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040182A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
|
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
|
WO2017023989A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US20180214428A1
(en)
|
2015-08-03 |
2018-08-02 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
WO2017024003A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023975A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
WO2017024021A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
WO2017023988A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023972A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017024015A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023980A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
WO2017024013A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
WO2017023987A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
US20180221352A1
(en)
|
2015-08-03 |
2018-08-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
WO2017023996A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
WO2017023993A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017024026A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
US10206908B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
|
WO2017024010A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
NZ742200A
(en)
|
2015-11-06 |
2023-01-27 |
Samumed Llc |
Treatment of osteoarthritis
|
|
AR108325A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
SI3464285T1
(sl)
|
2016-06-01 |
2023-02-28 |
Biosplice Therapeutics, Inc. |
Postopek za pripravo N-(5-(3-(7-(3-fluorofenil)-3H-imidazo(4,5-C)piridin-2-il)-1H-indazol-5- il)piridin-3-il)-3-metilbutanamida
|
|
EP3528808B1
(en)
|
2016-10-21 |
2021-10-06 |
BioSplice Therapeutics, Inc. |
Methods of using indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
|
|
KR102558716B1
(ko)
|
2016-11-07 |
2023-07-21 |
사뮤메드, 엘엘씨 |
단일-투여량, 즉시-사용가능한 주사용 제제
|
|
WO2020006115A1
(en)
|
2018-06-26 |
2020-01-02 |
Betty Tam |
Methods of treating cancer using a clk inhibitor
|
|
WO2020150552A2
(en)
|
2019-01-17 |
2020-07-23 |
Samumed, Llc |
Methods of treating cartilage disorders through inhibition of clk and dyrk
|